Impact of Five Prophylactic Filgrastim Schedules on Hematologic Toxicity in Early Breast Cancer Patients Treated With Epirubicin and CyclophosphamidePaola Papaldo, F. Calabresi, Francesca Conti et al.|Journal of Clinical Oncology|2005Cited by 96
Addition of Either Lonidamine or Granulocyte Colony-Stimulating Factor Does Not Improve Survival in Early Breast Cancer Patients Treated With High-Dose Epirubicin and CyclophosphamidePaola Papaldo, Paolo Marolla, Massimo Lopez et al.|Journal of Clinical Oncology|2003Cited by 76
Does Granulocyte Colony-Stimulating Factor Worsen Anemia in Early Breast Cancer Patients Treated With Epirubicin and Cyclophosphamide?Paola Papaldo, Francesco Cognetti, G. Ferretti et al.|Journal of Clinical Oncology|2006Cited by 42
Effect of Filgrastim on Serum Lactate Dehydrogenase and Alkaline Phosphatase Values in Early Breast Cancer PatientsPaola Papaldo, F. Cognetti, Serena Di Cosimo et al.|Cancer Investigation|2004Cited by 5
Myeloid Toxicity in Breast Cancer Patients Receiving Adjuvant Chemotherapy: What Is the Appropriate Use of Filgrastim?G. Ferretti, Paola Papaldo, Massimo Lopez et al.|Journal of Clinical Oncology|2006Cited by 2